Keros Therapeutics

$65.52
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.63 (-2.43%) As of 3:14 PM UTC today

Why Robinhood?

You can buy or sell KROS and other stocks, options, and ETFs commission-free!

About KROS

Keros Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on treatments for rare muscle diseases. The company was founded in 2015 and is headquartered in Lexington, MA. The listed name for KROS is Keros Therapeutics, Inc. Common Stock.

CEO
Jasbir S. Seehra
Employees
23
Headquarters
Lexington, Massachusetts
Founded
2015
Market Cap
1.39B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
159.68K
High Today
$67.50
Low Today
$65.70
Open Price
$67.50
Volume
43.34K
52 Week High
$88.80
52 Week Low
$19.10

Collections

KROS Earnings

-$5.11
-$3.41
-$1.70
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 9, After Hours

You May Also Like

FLNG
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure